Next Article in Journal
Validation of a Novel Diagnostic Test for Assessing the Risk of Peri-Implantitis through the Identification of the Microorganisms Present: A Pilot Clinical Study of Periopoc
Next Article in Special Issue
Sorbets as Functional Food Products, Unexplored Food Matrices, Their Challenges, and Advancements
Previous Article in Journal
Efficient Resource Allocation in Blockchain-Assisted Health Care Systems
Previous Article in Special Issue
Does the Nature of Added Bioactive Lipids Affect the Biological Properties of Yogurts?—Case Study Coconut and Avocado Oils
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Effect of Fortification of Tahini with Natural Plant Origin Raw Materials on Its Bioactivity

by
Panagiotis Achilladelis
,
Andreas Stergios Petsas
and
Haralabos Christos Karantonis
*
Laboratory of Food Chemistry and Technology and Quality of Animal Origin Food, Department of Food Science and Nutrition, School of the Environment, University of the Aegean, 81400 Myrina, Greece
*
Author to whom correspondence should be addressed.
Appl. Sci. 2023, 13(17), 9626; https://doi.org/10.3390/app13179626
Submission received: 27 July 2023 / Revised: 17 August 2023 / Accepted: 23 August 2023 / Published: 25 August 2023
(This article belongs to the Special Issue Editorial Board Members' Collection Series: Functional Foods)

Abstract

:
Food fortification is a strategic approach to enhance the nutritional quality of food by incorporating bioactive compounds derived from food by-products. The objective of this study was to assess the impact on bioactivity of tahini enriched with a 4% (w/w) lyophilized microwave-ultrasound assisted extract of red grape pomace from the Limnio variety and a 6% (w/w) freeze-dried aquafaba obtained from Lemnian chickpeas of the Panagia variety. The evaluation was conducted through in vitro experiments. The samples under study were extracted by the Bligh and Dyer method and analyzed for their polyphenolic content, as well as for their content in total flavonoids. Assessment of the antioxidant capacity of the extracts was determined in vitro by the ABTS, DPPH, CUPRAC, FRAP and human blood plasma oxidation inhibition (hBPOxi) assays, while the antiplatelet activity of the extracts was determined by the Platelet Activating Factor inhibition assay (PAFi). The bioactivity of fortified tahini (LAC) was increased compared to plain tahini (Control sample). Total phenolics and total flavonoids were increased by 76% and 78%, respectively (10.7 ± 0.2 vs. 6.02 ± 0.3 and 8.5 ± 0.14 vs. 4.76 ± 0.1 μmol Trolox/g, respectively). Antioxidant activities based on ABTS, DPPH, CUPRAC, FRAP and hBPOxi were increased by 101%, 65%, 77%, 73% and 110%, respectively (52.8 ± 0.7 vs. 26.3 ± 0.4; 20.1 ± 1.6 vs. 12.2 ± 0.2; 81.9 ± 0.4 vs. 46.1 ± 2.1; 46.4 ± 4.0 vs. 26.8 ± 0.8; and 12.2 ± 0.9 vs. 5.8 ± 0.2 μmol Trolox/g, respectively), and antiplatelet activity based on PAFi was also increased by 41% (0.19 ± 0.01 vs. 0.32 ± 0.02 mg, respectively). Red grape pomace extract and aquafaba boosted tahini’s in vitro antioxidant and antiplatelet capabilities. The results indicate that the valorization of grape and chickpea processing residuals may reduce waste and improve the nutritional value of tahini. Due to its antioxidant and antiplatelet activities, fortified tahini may contribute to the prevention of chronic diseases where oxidation and thrombosis play critical roles. This study exemplifies sustainable resource use and waste reduction, as well as the importance of circular economy strategies in enhancing diets and human welfare.

1. Introduction

Sesame seeds (Sesamum indicum L.) contain a multitude of phenolic compounds, which exhibit beneficial effects on human health. Phenolic components, known for their antioxidant, anti-inflammatory and hypolipidemic activities, and, specifically, sesame lignans like sesamin and sesamolin have attracted large interest regarding their nutritional benefits for humans in conditions such as atherosclerosis, hypertension, hyperlipidemia, obesity, diabetes, osteoporosis, arthritis and Alzheimer’s disease [1,2,3,4,5,6,7,8]. A number of studies with sesame oil have reported a reduction in oxidative stress and an increase in vitamin E levels [9,10]. However, there is limited data concerning the effect of tahini consumption on human health. A recent study shows that the ingestion of tahini enhances the biomarkers related to metabolic and antioxidant status throughout the postprandial period in healthy men [11], and a second study presents novel findings indicating that the consumption of tahini may have a beneficial impact on blood pressure, pulse rate and endothelial function in healthy men, implying that including tahini into one’s diet as a healthier alternative to snacks with unfavorable lipid profiles could be advantageous [12].
An alternative utilization of food by-products rich in bioactive compounds is their incorporation into other foods, thus making them functional [13,14,15].
Red grape pomace is a low-cost source of valuable phenolic compounds [16,17,18]. It has been studied extensively over the past two decades, with clear evidence indicating its effectiveness in reducing the risk of various diseases. Given the plethora of potential health benefits associated with grape phenolic compounds, there has been a growing demand for functional foods fortified with grape extract polyphenols [19,20].
On the other hand, chickpea boiling water called aquafaba produced at home or from canned chickpeas is usually discarded. However, it is valuable not only for its high content of health-promoting compounds, such as polyphenols, but also for its high protein content [21,22].
Red grape pomace and aquafaba are considered by-products of the wine and chickpea industries, respectively. In a circular economy framework, utilizing these by-products as fortifiers for tahini can help minimize waste and create value from materials that would otherwise be discarded. This aligns with the principles of sustainability and resource efficiency. At the same time, fortifying tahini with red grape pomace can enhance its nutritional profile, potential health benefits and appeal to health-conscious consumers.
The purpose of this study was to evaluate in vitro the fortification of tahini with an extract of red grape pomace of the Limnio variety and aquafaba from Lemian chickpeas of the Panagia variety and their effect on its bioactivity. Oxidation, inflammation and thrombosis mechanisms are directly involved in the development of chronic diseases and the study of food substances with possible antioxidant, anti-inflammatory and anti-thrombotic activity can reveal bioactivities that indicate a preventive effect against their development [23,24,25].

2. Materials and Methods

2.1. Reagents and Chemicals

Tahini was kindly offered by the Achilladelis-Lemnos company (Lemnos, Myrina, Greece). Folin–Ciocalteau reagent, anhydrous Na2CO3 and 6-hydroxy-2,5,7,8-tetremethychroman-2-carboxylic acid (Trolox) were purchased from Scharlab (Scharlab, S.L., Barcelona, Spain). 1,1-Diphenyl-2-picryl-hydrazyl (DPPH), 2,20-Azino-bis-(3-ethylbezothiazoline-6-sulphonic acid (ABTS) and Neocuproine were purchased from Glentham Life Sciences (Corsham, UK). Methanol, ammonium acetate, sodium chloride, sodium dihydrogen phosphate dihydrate, copper chloride dihydrate and potassium persulfate were all purchased from Chem-Lab (Zedelgem, Belgium).

2.2. Preparation of Fortification Materials

2.2.1. Preparation of Sesame Cake

The preparation of the sesame cake was done by removing the oil of sesame seeds using n-hexane. After checking for obvious defects or residues, 100.0 g of Lemnian sesame seeds were pulverized for 10 s by a laboratory mill (IKA, A 10 Basic, Staufen, Germany), and then 300.0 mL of n-hexane was added. This was followed by stirring on a magnetic stirrer (Steroglass s.r.l., Steromag, Perugia, Italy) for 30 min, decanting from the solvent and drying in an oven (Binder GmbH, ED 115, Tuttlingen, Germany) at 70 °C for 72 h. The ground-defatted sesame seeds were sieved in a household sieve and stored at room temperature until use (Figure 1A).

2.2.2. Limnio Red Grape Pomace Extract

An amount of 350.0 g of red grape pomace of Limnio variety (Figure 1B) was treated in a microwave extractor for natural products (Milestone Srl, ETHOS X, Milan, Italy) at 350 Watts for 33 min. Then, 25.0 g of the microwave-treated pomace was extracted with ultrasounds in 250 mL of water (10% w/v) in a bath sonicator (Elma Schmidbauer GmbH, Elmasonic P, Singen, Germany) at 37 KHz, with 100% power at 70 °C for 30 min. The extract was filtered and stored at −80 °C until further analysis.

2.2.3. Lyophilization—Drying of Extract

The extracts were lyophilized using a Genevac miVac Duo Concentrator freeze-drying system (Genevac Ltd., Ipswich, UK). The samples were dissolved in dH2O, and sesame cake was added in an amount so that the ratio was 50:50 (w/v). After concentration, they were pulverized in a laboratory mill (IKA, A 10 Basic, Staufen, Germany) (Figure 1C), while the dry extract weight was calculated, and the final ratio (extract: sesame cake) was (45.35:54.65). The pure proportion of sesame cake used in the fortification of all samples was 5%.

2.2.4. Preparation of Freeze-Dried Aquafaba

The preparation of aquafaba was done according to He et al. [26] with minor modifications. Dry chickpeas of Lemnos variety Panagia were soaked in a ratio of 1:4 with potable soft water for 16 h at 7 °C. The water was then discarded. In a household pressure cooker (Fissler, 8 L, Idar-Oberstein, Germany) 2.0 Kg of soaked chickpeas and 3.0 L of distilled water at a ratio of (2:3) were added and boiled for 30 min.
Aquafaba was separated from cooked chickpeas using a stainless-steel filter with 1 mm holes and stored at −80 °C for 24 h. The aquafaba samples were then freeze-dried (Biobase Biodusrty, Shandong, Co., Ltd., BK-FD10PT, Jinan, China) and stored at room temperature until use (Figure 1D). The proportion of freeze-dried aquafaba used in the fortification was 6%.

2.3. Tahini Fortification

Tahini was fortified with the red grape pomace of Limnio variety extract at 0.25%, 0.5%, 1.0%, 2.0% and 4.0% (w/w), leading to increased antioxidant activities based on ABTS assay at 10%, 13%, 20%, 35% and 64%, respectively (Table 1). The 4.0% fortification was acquired for the rest of the study due to its highest effect on the antioxidant activity of the final product. Katarzyna Włodarczyk et al. reported an antioxidant activity for aquafaba based on ABTS assay equal to 20.97 μmol Trolox equivalents per one gram. Based on this study, a 6% fortification was acquired for our study, estimating that this would increase about five times the antioxidant activity of tahini [27]. For better results management, tahini mixtures were prepared with each fortification material separately. Thus, we had the following mixtures with the proportions shown in Table 2: Control: tahini; C: tahini and sesame cake; LC: tahini, sesame cake and lyophilized extract of red grape pomace of Limnio variety; AC: tahini, sesame cake and freeze-dried aquafaba from Panagia variety Lemnian chickpeas; and LAC: tahini, sesame cake, lyophilized extract of red grape pomace of Limnio variety and freeze-dried aquafaba from Panagia variety Lemnian chickpeas. In addition, as a reference, raw materials were also studied: Cake: sesame cake; LMU: lyophilized extract of red grape pomace of Limnio variety; and AF: freeze-dried aquafaba from Panagia variety Lemnian chickpeas.

2.4. Extraction of the Fortified Tahini

A quantity of the samples under study (2.0 g) was placed in 50.0 mL screw cap polypropylene centrifuge tubes. Methanol in a volume of 4.0 mL was added and stirred in a vortex stirrer (Labbox Labware S.L., LBX instruments V05 series, Barcelona, Spain) for 1.0 min. Then, mixtures were stirred on an orbital shaker (Gesellschaft für Labortechnik mbH, GFL 3017, Burgwedel, Germany) at 250 rpm for 10 min.
Table 2. Proportions of tahini fortification.
Table 2. Proportions of tahini fortification.
Samples% Tahini% Sesame Cake% Pomace Extract% Aquafaba
Control100---
C955--
LC9154-
AC895-6
LAC85546
Control: tahini; C: tahini and sesame cake; LC: tahini, sesame cake and lyophilized extract of red grape pomace of Limnio variety; AC: tahini, sesame cake and freeze-dried aquafaba from Panagia variety Lemnian chickpeas; and LAC: tahini, sesame cake, lyophilized extract of red grape pomace of Limnio variety and freeze-dried aquafaba from Panagia variety Lemnian chickpeas.
The mixtures were subjected to further separation into their hydrophilic and lipophilic components through a biphasic solvent system formation according to the method of Bligh and Dyer [28] with slight modifications. Volumes of 1.6 mL dH2O and 2.0 mL chloroform were added, resulting in a ratio of chloroform:methanol:water equal to 1:2:0.8 (v/v/v), and stirred on the orbital shaker at 250 rpm for another 5 min. The solutions were centrifuged (Orto Alresa—Alva-rez Redondo SA, Digicen 21R, Madrid, Spain and HERMLE Labortechnik GmbH, Z383, Wehingen, Germany) at 1500× g for 10 min and the supernatant was poured into 15 mL polypropylene screw tubes. Then, 2.0 mL chloroform and 2.0 mL dH2O were added to obtain a final ratio of chloroform:methanol:water equal to 1:1:0.9 (v/v/v) to create the biphasic system. The phases were separated by centrifugation at 1500× g for 5 min (HERMLE Labortechnik GmbH, Z383, Wehingen, Germany); the lower phase (chloroformic) was discarded and the upper (water-methanolic) was stored at −40 °C for 24 h. Then, 1.0 mL extract was transferred to 1.5 mL capped polypropylene Eppendorf vials and centrifuged (Hermle Labortechnik GmbH, Z216 MK, Wehingen, Germany) at 20,000× g for 5 min. After that, 0.800 mL without sediment were transferred to new capped polypropylene Eppendorf vials and stored at −40 °C until further analysis.

2.5. Determination of Total Phenolic Content

Total phenolic content in the extracts was determined according to the method of Singleton and Rossi [29] with minor modifications. Total phenolics assay was conducted by mixing aliquots of fortified tahini extracts with distilled water up to the volume of 1.8 mL and 0.1 mL Folin–Ciocalteu reagent. After that, the samples were vigorously stirred and incubated in the dark for 2 min. Then, 0.3 mL of aqueous Na2CO3 20% (w/v) was added and the samples were vigorously stirred and incubated in a water bath at 40 °C for 30 min. Absorbance was measured at 765 nm using a photometer (Rayleigh, VIS-7220G, Shenzhen, China). A standard curve was prepared with gallic acid. Final results were given as mg of gallic acid equivalents per one g of final product. Every sample was tested in triplicate.

2.6. Determination of Total Flavonoid Content

Total flavonoid assay was conducted by mixing aliquots of fortified tahini extracts with distilled water up to the volume of 0.740 mL and 0.030 mL 5% (w/v) NaNO2. After vigorously vortexing at 2500 rpm for 5 s and leaving samples for 5 min, 0.03 mL of 10% (w/v) AlCl3 was added, followed by stirring. After 6 min, 0.2 mL NaOH 1 M was added, and the samples were vortexed again. Absorbance was measured at 510 nm using a photometer (Rayleigh, VIS-7220G, Shenzhen, China). A standard curve was prepared with rutin. Results were given as mg of rutin equivalents per one g of final product. Every sample was tested in triplicate.

2.7. Evaluation of the Antioxidant Capacity

The antioxidant capacity of the extracts was assessed by the ABTS, DPPH, CUPRAC and FRAP assays.

2.7.1. ABTS Assay

Determination of ABTS radical scavenging activity of extracts was performed as described elsewhere [30] with minor modifications. ABTS radical cation (ABTS•+) was generated by the oxidation of ABTS with potassium persulphate (K2S2O8). The ABTS•+ was produced by reacting to a 7.0 mmol/L stock solution of ABTS with 2.45 mmol/L potassium persulphate (final concentration). The ABTS•+ solution was diluted (with distilled water) to an absorbance of 0.700 at 734 nm. A volume of 1.0 mL of ABTS•+ was added to aliquots of fortified tahini extracts, or appropriate standard solution of Trolox, and were vigorously stirred. Samples were incubated in the dark for 15.0 min at ambient temperature, and the absorbance was measured at 734 nm using a photometer (Rayleigh, VIS-7220G, Shenzhen, China). Results were expressed as μmol Trolox/g final product using the standard Trolox solutions assayed at conditions similar to the sample extracts. Every sample was tested in triplicate.

2.7.2. DPPH Assay

The capacity of the fortified tahini extracts to scavenge the free radical of DPPH was assessed by a modified method as previously described [30]. DPPH working solution was 0.6 mM in methanol with an absorbance of 0.600 at 515 nm. A volume of 1.0 mL of the working solution of DPPH was added to aliquots of fortified tahini extracts or the appropriate standard solution of Trolox, followed by vigorous stirring. Samples were incubated in the dark for 15 min at ambient temperature, and the absorbance was measured at 515 nm against a reference sample containing methanol instead of a sample aliquot using a photometer (Rayleigh, VIS-7220G, Shenzhen, China). Results were expressed as μmol Trolox/g final product using the standard Trolox solutions assayed at conditions similar to the sample extracts. Every sample was tested in triplicate.

2.7.3. CUPRAC Assay

The reducing potential of the sample was determined using the CUPRAC assay as previously described [31]. Different volumes of the extracts were transferred in test tubes and solutions of 0.3 mL CuCl2∙2H2O 10 mM, 0.3 mL neocuproine 7.5 mM and 0.3 mL ammonium acetate buffer 1Μ, pH = 7.0, were added. A final volume of 1.2 mL was reached with dH2O. The samples were well stirred and incubated at room temperature for 30 min. After incubation, the absorbance of the samples was measured at 450 nm (Rayleigh, VIS-7220G, Shenzhen, China). A standard curve was prepared using different concentrations of Trolox. The antioxidant activity was expressed as μmol Trolox/g final product. Every sample was tested in triplicate.

2.7.4. FRAP Assay

The reducing potential of the samples was determined using the FRAP assay as described elsewhere [32]. The method is based on the reduction of the Fe3+-tripyridyltriazine complex to its ferrous-colored form at low pH in the presence of antioxidants. The FRAP reagent was freshly prepared daily and contained a ratio of 1:1:1 (v/v/v) of TPTZ (2,4,6-tripyridyl-s-triazine) 10 mM solution in HCl 40 mM, FeCl3∙6H2O 20 mM and acetate buffer 3.0 mM, pH = 3.6. The aliquots of the extracts were transferred in glass test tubes and dissolved in distilled water to a final volume of 0.9 mL, followed by an addition of 0.3 mL of FRAP solution. The samples were stirred and incubated for 10 min in a 40 °C water bath, and the absorbance was measured at 593 nm using a photometer (Rayleigh, VIS-7220G, Shenzhen, China). A standard curve was prepared using different concentrations of Trolox. The antioxidant activity was expressed as μmol Trolox/g final product. Every sample was tested in triplicate.

2.8. In Vitro Inhibition of Plasma Oxidation

In vitro inhibition of plasma oxidation was evaluated as previously reported [33] with minor modifications. Aliquots of the extracts were transferred in glass test tubes and dried under a stream of nitrogen. Then, they were dissolved in phosphate buffer solution, pH = 7.4, 146 mM in NaCl to a final volume of 0.88 mL. A volume of 0.02 mL of human plasma was added, followed by gentle shaking. In the next step, the oxidation reaction was started by the addition of 0.1 mL of CuSO4∙5H2O 1 mM aqueous solution and the samples were placed immediately into the chamber of the spectrophotometer (PerkinElmer Inc., Lambda 25, Waltham, MA, USA) equipped with an 8 position thermostated sample changer. The absorbance was continuously recorded for 3.0 h at 245 nm at 37 °C. Lag times from the resultant sigmoid curves were calculated as the time needed for the antioxidants to be oxidized, corresponding to the period of time that plasma resists oxidation. The percentage of the inhibition of in vitro plasma oxidation induced by the extracts was evaluated by comparing the lag time of each tested sample containing extract to a reference sample that did not contain extract. Also, a standard curve was prepared using different concentrations of Trolox. Results were expressed as μmol Trolox/g final product using the standard Trolox solutions assayed at conditions similar to the sample extracts.

2.9. In Vitro Antiplatelet Activity

The in vitro antiplatelet activity of extracts was evaluated on a Born-type aggregometer by their ability to inhibit the thrombotic and inflammatory lipid mediator of Platelet Activating Factor (PAF) towards human platelet rich plasma (PRP) [33]. Aliquots of the extracts and PAF solution were evaporated under a stream of nitrogen and reconstituted in bovine serum albumin (BSA) 2.5 mg/mL saline. After that, aliquots of 0.25 mL of PRP along with stir bars were placed in siliconized glass cuvettes and were incubated for 15 min in the incubation wells of the aggregometer at 37 °C (Chrono-log Corporation, 500CA, Havertown, PA, USA). The platelet response induced by PAF 2.6 × 10−7 M, final concentration, in human PRP before (considered as 0% inhibition) and after the addition of various amounts of the examined samples was recorded by the aggregometer upon stirring at 1200 rpm. The amounts of extracts required for 50% inhibition (IC50) of PAF activity were calculated using the linear plot of the percentage inhibition, ranging from 20 to 80%, versus different amounts of the samples. The in vitro antiplatelet activity was expressed as mg final product required for 50% inhibition of PAF activity towards human PRP.

2.10. Statistical Analysis

Case samples tested in triplicate data are presented as mean ± standard deviation. One-way ANOVA with post-hoc Tukey test was performed to assess statistical significance (p < 0.05). Statistical analysis was performed with the statistical package IBM SPSS Statistics for Windows (IBM, version 28.0, Armonk, NY, USA).

3. Results and Discussion

3.1. Total Phenolics

The mixture of tahini, sesame cake, lyophilized pomace extract and freeze-dried aquafaba (LAC) showed the highest concentration of total phenolics (10.71 ± 0.18 mg GAE/g final product), followed by the mixture of tahini, sesame cake and lyophilized pomace extract (LC) (9.01 ± 0.12 mg GAE/g final product), the mixture of tahini, sesame cake and freeze-dried aquafaba (AC) (7.34 ± 0.34 mg GAE/g final product), the plain tahini (Control) (6.02 ± 0.03 mg GAE/g final product) and, finally, the mixture of tahini and sesame cake (C) (5.82 ± 0.16 mg GAE/g final product) (Table 3). Both the lyophilized pomace extract (LMU) (44.86 ± 3.32 mg GAE/g final product) and the freeze-dried aquafaba (AF) (18.87 ± 0.66 mg GAE/g final product) had a higher concentration of total phenolics than the tahini sample, so the order of its fortified samples in the content of phenolic components was as expected: LAC > LC > AC > C ≈ Control, since LMU > AF > Cake > Control. Among the fortified samples, all three (LC, AC, LAC) had significantly higher amounts of total phenolics than plain tahini (Control) (p < 0.001, p = 0.002 and p < 0.001, respectively). Sesame cake (Cake) had 6.89 ± 0.19 mg GAE/g final product (Table 3).

3.2. Total Flavonoids

The mixture of tahini, sesame cake and lyophilized pomace extract (LC) together with the mixture of tahini, sesame cake, lyophilized pomace extract and freeze-dried aquafaba (LAC) presented the highest concentration of total flavonoids (9.00 ± 0.36 mg RE/g final product and 8.45 ± 0.14 mg RE/g final product, respectively), followed by the plain tahini (Control) (4.76 ± 0.10 mg RE/g final product), the mixture of tahini and sesame cake (C) (4.49 ± 0.01 mg RE/g final product) and, finally, the mixture of tahini, sesame cake and freeze-dried aquafaba (AC) (4.07 ± 0.04 mg RE/g final product) (Table 3).
Freeze-dried aquafaba (AF) had the lowest content of total flavonoids of the fortification materials, but also in relation to the plain tahini (Control), with only 1.10 ± 0.03 mg RE/g final product.
Therefore, the reduction of total flavonoids of AC relative to Control (p = 0.001) and the approximately equal concentrations of LC and LAC samples were expected. However, there is a significant difference between these samples (p = 0.009). The lyophilized pomace extract (LMU) had a total flavonoid content of 61.76 ± 3.74 mg RE/g final product, resulting in an almost twofold increase of the flavonoid content in the fortified samples LC and LAC compared to the plain tahini (Control) (p < 0.001 and p < 0.001, respectively). Sesame cake (Cake) had 5.01 ± 0.02 mg RE/g final product (Table 3).

3.3. Antioxidant Capacity

3.3.1. ABTS Assay

All samples showed antioxidant activity through scavenging radical cation of ABTS. The best results were shown by the mixture of tahini, sesame cake, lyophilized pomace extract and freeze-dried aquafaba (LAC), which exerted an activity equivalent to 52.8 ± 0.66 μmol Trolox per one gram of final product. LAC was followed by the mixture of tahini, sesame cake and lyophilized pomace extract (LC), with 47.8 ± 2.50 μmol Trolox/g, the mixture of tahini, sesame cake and freeze-dried aquafaba (AC), with 31.6 ± 0.86 μmol Trolox/g, and, finally, the plain tahini (Control) and the mixture of tahini and sesame cake (C), with 26.3 ± 0.36 μmol Trolox/g and 25.3 ± 0.72 μmol Trolox/g, respectively (Table 4).
LAC and LC had similar results (p > 0.05) although freeze-dried aquafaba (AF) with activity equivalent to 38.8 ± 3 μmol trolox/g was lower compared to 26.3 ± 0 μmol trolox/g required from the plain tahini (Control) (p < 0.001); this was possibly due to the very potent lyophilized pomace extract (LMU) with activity equal to 338.1 ± 2.54 μmol Trolox/g. However, among the fortified samples, all three (LC, AC and LAC) had a significant difference compared to plain tahini (Control) (p < 0.001, p = 0.002 and p < 0.001, respectively). As for the sesame cake (Cake), the activity was 31.1 ± 2.71 μmol trolox/g (Table 4).

3.3.2. DPPH Assay

All samples showed antioxidant activity using the DPPH free radical scavenging assay. Specifically, as in the ABTS assay, the best results were presented by the mixture of tahini, sesame cake, lyophilized pomace extract and freeze-dried aquafaba (LAC) and the mixture of tahini, sesame cake and lyophilized pomace extract (LC) with 20.1 ± 1.65 μmol Trolox and 20.9 ± 0.46 μmol Trolox per g final product, respectively. They were followed by plain tahini (Control) (12.2 ± 0.18 μmol Trolox/g final product), the mixture of tahini, sesame cake and freeze-dried aquafaba (AC) (12.0 ± 0.19 μmol Trolox/g final product) and the mixture of tahini and sesame cake (C) (11.7 ± 0.18 μmol Trolox/g final product) (Table 4).
According to the DPPH assay, the antioxidant capacity of the freeze-dried aquafaba (AF) with a value of 10.6 ± 1.10 μmol Trolox/g final product was not statistically different compared to plain tahini (Control) (p > 0.05). In addition, sesame cake (Cake) was also at the same level of antioxidant capacity with a value equal to 12.2 ± 0.32 μmol Trolox/g final product (p > 0.05). Therefore, similar results of Control, AC and C samples were expected. The lyophilized pomace extract (LMU) again showed very high activity with 181.7 ± 10.1 μmol Trolox/g final product, creating a significant difference between both LC and LAC samples compared with plain tahini (Control) (p < 0.001 and p < 0.001, respectively), while there was no significant difference between them (p > 0.05) (Table 4).

3.3.3. CUPRAC Assay

Based on the results, it appears that tahini and its fortification materials exhibit antioxidant activity through the reduction of copper ions by antioxidants, with the mixture of tahini, sesame cake, lyophilized pomace extract and freeze-dried aquafaba (LAC) showing greater antioxidant capacity (81.9 ± 0.44 μmol Trolox/g final product). The order of the samples with the highest antioxidant capacity after LAC was as follows: mixture of tahini, sesame cake and lyophilized pomace extract (LC) (75.0 ± 2.22 μmol Trolox/g final product) > mixture of tahini, sesame cake and freeze-dried aquafaba (AC) (49.7 ± 2.60 μmol Trolox/g final product) > mixture of tahini and sesame cake (C) (46.1 ± 1.44 μmol Trolox/g final product) > tahini (Control) (46.1 ± 2.14 μmol Trolox/g final product) (Table 4).
Both lyophilized pomace extract (LMU) (488.0 ± 5.04 μmol Trolox/g final product) and freeze-dried aquafaba (AF) (62.7 ± 4.46 μmol Trolox/g final product) had a higher antioxidant capacity than the plain tahini, so the order of its fortified samples in antioxidant activity through reduction of copper ion capacity by antioxidants was as expected; LAC > LC > AC ≈ C ≈ Control, since LMU > AF > Cake ≈ Control. Among the fortified samples, only LC and LAC had a significant difference compared to plain tahini (Control) (p < 0.001 and p < 0.001, respectively), while they also had a significant difference between themselves (p = 0.041). Sesame cake (Cake) had 51.2 ± 1.03 μmol Trolox/g final product (Table 4).

3.3.4. FRAP Assay

Based on the results, it appears that tahini and its fortification materials exhibit antioxidant activity through the reduction of ferric to ferrous form of TPTZ, with the mixture of tahini, sesame cake, lyophilized pomace extract and freeze-dried aquafaba (LAC) exhibiting greater antioxidant capacity (46.4 ± 3.99 µmol Trolox/g final product). The order of the samples with the highest antioxidant capacity after LAC was as follows: mixture of tahini, sesame cake and lyophilized pomace extract (LC) (43.7 ± 1.60 μmol Trolox/g final product) > mixture of tahini, sesame cake and freeze-dried aquafaba (AC) (26.9 ± 0.62 μmol Trolox/g final product) = mixture of tahini and sesame cake (C) (26.9 ± 0.50 μmol Trolox/g final product) > tahini (Control) (26.8 ± 0.75 μmol Trolox/g final product) (Table 4).
According to the FRAP assay, freeze-dried aquafaba (AF) and sesame cake (Cake) had approximately the same antioxidant capacity (26.4 ± 2.34 and 29.9 ± 0.08 μmol Trolox/g final product, respectively) compared to the plain tahini (Control) (p > 0.05), thus the similar results of Control, AC and C samples were expected (p > 0.05). The lyophilized pomace extract (LMU) showed a very high activity again with 263.3 ± 7.98 μmol Trolox/g final product, so the LC and LAC samples did not have a significant difference between them (p > 0.05), while they did have it with plain tahini (Control) (p < 0.001 and p < 0.001, respectively) (Table 4).

3.4. In Vitro Inhibition of Plasma Oxidation

Oxidation of plasma lipoproteins plays an important role in atherogenesis, since, at the molecular level, oxidatively modified molecules on oxidized LDLs initiate the events of atherosclerosis development [24]. The in vitro inhibition of plasma oxidation from extracts was expressed as μmol Trolox/g final product. The more Trolox equivalents per g of final product correspond to a sample, the greater the protective effect against the oxidation of plasma lipoproteins.
The mixture of tahini, sesame cake and lyophilized pomace extract (LC) and the mixture of tahini, sesame cake, lyophilized pomace extract and freeze-dried aquafaba (LAC) had the highest activities equal to 13.9 ± 1.1 and 12.2 ± 0.9 μmol Trolox/g final product, respectively (p < 0.05). Lower activities were recorded in tahini (Control) with 5.8 ± 0.2 μmol Trolox/g final product, mixture of tahini and sesame cake (C) with 6.0 ± 0.4 μmol Trolox/g final product and mixture of tahini, sesame cake and freeze-dried aquafaba (AC) with 5.2 ± 0.2 μmol Trolox/g final product (Figure 2).
The freeze-dried aquafaba (AF) with a value of 4.7 ± 0.5 exerted the lowest activity (p < 0.05) followed by sesame cake (Cake) with an activity of 6.8 ± 0.5, which was comparable to Control, C, AC and Cake (p > 0.05) with values equal to 5.8 ± 0.2, 6.0 ± 0.4, 5.2 ± 0.2 and 6.8 ± 0.5 μmol Trolox/g final product, respectively. Lyophilized pomace extract (LMU) had the highest activity equal to 43.5 ± 2.9 μmol Trolox/g final product, which was about three times more than those of the LC and LAC (p < 0.05) (Figure 2).

3.5. In Vitro Antiplatelet Activity

The in vitro antiplatelet activity of each extract was expressed as the equivalent amount, in mg final product, required for 50% inhibition of PAF activity (IC50) toward human platelet rich plasma (PRP). The smallest required amount of mg final product to achieve the IC50, thus the greater potential antiplatelet capacity, was presented by the mixture of tahini, sesame cake, lyophilized pomace extract and freeze-dried aquafaba (LAC) with a requirement of 0.19 ± 0.01 mg final product. It is followed by plain tahini (Control) with 0.32 ± 0.02 mg final product, the mixture of tahini, sesame cake and freeze-dried aquafaba (AC) with 0.37 ± 0.01 mg final product, the mixture of tahini and sesame cake (C) with 0.44 ± 0.03 mg final product and the mixture of tahini, sesame cake and lyophilized pomace extract (LC) with 0.45 ± 0.04 mg final product (Figure 3).
No inhibitory activity was detected in lyophilized pomace extract (LMU). Freeze-dried aquafaba (AF) had the highest activity of the fortification materials with 0.02 ± 0.00 mg final product required for 50% inhibition of PAF activity toward PRP. LC is in agreement with the not detectable activity for LMU, while LAC seems to be in line with the results of AF, while sesame cake (Cake) required 0.37 ± 0.03 mg final product (Figure 3). The results show lower antiplatelet activities for all extracts related to sesame and grape pomace (Control, C, LC, LAC, Cake and LMU) compared to aquafaba (AF) and indicate that antiplatelet activity in the fortified tahini (LAC) comes from the addition of AF and its positive synergistic activity with the extract of grape pomace (LMU). This is in line with the synergistic effect that has been recently reported for grape seed and grape skin extracts, where grape seed and grape skin extracts did not exert antiplatelet activity when tested individually, while the combination of them significantly inhibited platelet activation [34].
Sesame cake lacks the majority of the lipophilic molecules that are contained in sesame seeds and tahini. Since PAF is a lipid mediator, it is possible that lipophilic molecules in tahini interact with its receptor in order to inhibit its activity more effectively. Therefore, the incorporation of sesame cake and red grape pomace extract in C and LC lowers the concentration of lipophilic molecules with antiplatelet activity against PAF, leading to increased IC50 values. Moreover, the significant difference noticed in IC50 values for LAC compared to AC seems to be the result of a positive synergistic activity that leads to a higher antiplatelet activity when AF and LMU coexist.
It is worth noting that there is a difference between the fortification materials about their antioxidant and antiplatelet activities. Antiplatelet activity has been referred to as independent of antioxidants due to the different mechanisms and receptors that participate in each case [35]. Moreover, Platelet Activating Factor, due to its biochemical actions, has attracted the attention of the scientific community as a molecule involved in all the fundamental states of the development of atherosclerosis, the inhibition of which could be a way to counteract the development of atherosclerosis and, by extension, the prevention of cardiovascular diseases [24].
Results concerning total phenolic and flavonoid content in Limnio grape pomace are in line with recent studies that showed total phenolics in the range of 33.39 ± 0.59 to 92.15 ± 1.75 mg GAE/g [36,37,38] and total flavonoids in the range of 12.15 ± 1.20 to 51.36 mg quercetin equivalent/g [36], depending on the extraction conditions. On the other hand, other investigators have determined lower total phenolics in aquafaba (5.50 mgGAE/g) compared to our study (18.87 mgGAE/g) [39]. This difference may exist due to the different varieties and storage conditions of chickpeas [40].
The Limnio grape pomace extract and freeze-dried aquafaba of Lemnian chickpeas from Panagia exhibit a notably greater concentration of total phenolics in comparison to tahini (44.86 ± 3.32 and 18.87 ± 0.66 > 6.02 ± 0.03, respectively; p < 0.05). The Limnio grape pomace extract exhibits a notably greater concentration of total flavonoids in comparison to tahini (61.76 ± 3.74 > 4.76 ± 0.1; p < 0.05). The findings of this study suggest that the utilization of Limnio grape pomace and aquafaba derived from Lemnian chickpeas sourced from Panagia can be considered as suitable options for fortifying tahini. Incorporating these raw materials in small quantities can effectively enhance the overall content of total phenolics and flavonoids in tahini. The fortification of tahini with the aforementioned materials at percentages of 4% and 6% (w/w) resulted in a significant increase in the levels of total phenolics and flavonoids, with an average increase of 77.9 ± 2.1% and 77.5 ± 0.8%, respectively.
Fortification of tahini with Limnio grape pomace extract and Lemnian chickpeas aquafaba from Panagia increased the antioxidant capacity of the fortified tahini by 100.8 ± 0.2%, 64.6 ± 11.1%, 77.7 ± 7.3% and 72.9 ± 10.1%, as was assessed by ABTS, DPPH, CUPRAC and FRAP assays, respectively. In vitro plasma oxidation was also significantly increased in fortified tahini compared to the Control by 110.2 ± 8.3% (p < 0.05).
Polyphenols are the predominant class of antioxidants found in the human diet through plant foodstuffs. At the same time, it has become widely accepted that oxidative stress is an important contributor to the onset and progression of a number of different diseases. These chemicals have distinct ways by which they exert their antioxidant capacity. The constant link between the consumption of polyphenol-rich foods and the prevention of certain chronic and degenerative diseases has led to an increase in interest in phenolic compounds. This interest has been growing steadily over the past many years. It has been demonstrated that these molecules are capable of performing a diverse range of biological tasks, such as the neutralization of free radicals, amongst others [41,42,43,44].
Grape pomace is a significant reservoir of antioxidant chemicals such as phenolics that have been demonstrated to have free radical inhibitory properties in many in vitro experiments [45]. The antioxidant capacity of aquafaba has been previously discussed. There exists documented evidence suggesting that aquafaba, when discarded, contains bioactive polyphenols. Furthermore, previous studies have provided evidence that chickpeas’ polyphenols have the potential to leach out into the water during the boiling process, resulting in their degradation into smaller, more bioactive molecules. In the case of chickpeas’ aquafaba, the process involves at least the degradation of lignin into syringic acid and the conversion of anthocyanins into 4-hydroxy benzoic acid [46,47].
In addition, in the present study, in vitro antiplatelet activity toward PAF was significantly increased by 31.6 ± 1.7% in fortified tahini compared to the Control (p < 0.05).
According to our knowledge, there are no studies concerning anti-PAF activity from red grape pomace extracts. However, studies in wine samples report the existence of lipid molecules that may come from grape skin with antiplatelet activities toward PAF [48]. Moreover, the acetylation of phenolic compounds that render them more hydrophobic may increase their antiplatelet activity toward PAF [49]. The results of this study are in line with the above findings concerning the high antioxidant capacity of LMU and the not detectable antiplatelet activity.
According to our knowledge, there are no studies concerning the antiplatelet activity of aquafaba from chickpeas. However, phenolic compounds from legumes have been referred to not only for their antioxidant activities but also for their antithrombotic ones [50]. Antiplatelet activity toward TRAP-6 and ADP has been recently reported for aqueous extracts of common beans (Phaseolus vulgaris L.) [51]. The results of this study are in accordance with the above findings concerning the detected antioxidant and antiplatelet capacities of AF.
Overall, the results indicated the effectiveness of grape pomace extracts from Limnio and aquafaba from Lemnian chickpeas of Panagia in increasing antioxidant and antiplatelet bioactivities of tahini, thus giving it an added value due to a higher nutritional value.

4. Conclusions

Both the extract of red grape pomace of the Limnio variety and the aquafaba from Lemnian chickpeas of the Panagia variety increased the bioactivity of tahini. The percentages of fortification and the parallel study of the lipophilic compounds, as they may act synergistically, presenting completely different results is an area for further research.
When these foods are part of a balanced diet, enhancing the antioxidant and antiplatelet activities the foods by creating highly active natural additives, especially when derived from food by-products, can be beneficial to human health and help prevent the development of chronic diseases, which have as their main causal mechanisms oxidative stress, inflammation and thrombosis as occurs in cardiovascular diseases, diabetes mellitus type II, obesity and cancer.
The combination of red grape pomace extract and aquafaba presents a substantial supply of antioxidants and antiplatelet agents, resulting in a notable enhancement of the in vitro antioxidant and antiplatelet properties of tahini. Through the utilization of the residual materials generated by the grape and chickpea processing sectors, this intervention effectively mitigates wastage while concurrently converting these remnants into valuable resources that augment the health-promoting attributes of the end product. This practice not only adheres to the principles of the circular economy, which emphasize the efficient use of resources throughout the production process, but also serves as a prime example of value creation within the food industry.

Author Contributions

Conceptualization, H.C.K.; methodology, H.C.K.; software, P.A.; formal analysis, P.A.; investigation, P.A., H.C.K. and A.S.P.; resources, H.C.K.; data curation, P.A. and H.C.K.; writing—original draft preparation, P.A.; writing—review and editing, H.C.K. and A.S.P.; supervision, H.C.K.; project administration, H.C.K.; funding acquisition, H.C.K. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by EPAnEk -NRSF 2014–2020; Operational Program “Competitiveness, Entrepreneurship and Innovation”, Call 111 “Support of Regional Excellence” in the context of the implementation of the program AGRICA II: AGrifood Research and Innovation Network of Excellence of the Aegean, which is co-financed by the European Regional Development Fund (ERDF), MIS code: 5046750.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. Kim, M.-Y.; Kim, S.; Lee, J.; Kim, J.-I.; Oh, E.; Kim, S.-W.; Lee, E.; Cho, K.-S.; Kim, C.-S.; Lee, M.-H. Lignan-Rich Sesame (Sesamum indicum L.) Cultivar Exhibits In Vitro Anti-Cholinesterase Activity, Anti-Neurotoxicity in Amyloid-β Induced SH-SY5Y Cells, and Produces an In Vivo Nootropic Effect in Scopolamine-Induced Memory Impaired Mice. Antioxidants 2023, 12, 1110. [Google Scholar] [CrossRef] [PubMed]
  2. Hadipour, E.; Emami, S.A.; Tayarani-Najaran, N.; Tayarani-Najaran, Z. Effects of Sesame (Sesamum indicum L.) and Bioactive Compounds (Sesamin and Sesamolin) on Inflammation and Atherosclerosis: A Review. Food Sci. Nutr. 2023, 11, 3729–3757. [Google Scholar] [CrossRef] [PubMed]
  3. Chakraborty, A.; Chatterjee, N.; Dey, S.; Dhar, P. Sesame Lignans as Promising Anti-Inflammatory Agent: Exploring Novel Therapeutic Avenues with in Silico and Computational Approach. Indian. J. Chem. Technol. 2023, 30, 547–559. [Google Scholar] [CrossRef]
  4. Mahmoodi, M.R.; Abbasi, M.M. Therapeutic Effectiveness of Sesame Preparations and Its Bioactive Ingredients in Management of Cardiometabolic Syndrome in Diabetes Mellitus: A Systematic Review. Curr. Diabetes Rev. 2023, 19, 79–93. [Google Scholar] [CrossRef]
  5. Dossou, S.S.K.; Xu, F.-T.; Dossa, K.; Zhou, R.; Zhao, Y.-Z.; Wang, L.-H. Antioxidant Lignans Sesamin and Sesamolin in Sesame (Sesamum indicum L.): A Comprehensive Review and Future Prospects. J. Integr. Agric. 2023, 22, 14–30. [Google Scholar] [CrossRef]
  6. Li, M.; Luo, J.; Nawaz, M.A.; Stockmann, R.; Buckow, R.; Barrow, C.; Dunshea, F.; Suleria, H.A.R. Phytochemistry, Bioaccessibility, and Bioactivities of Sesame Seeds: An Overview. Food Rev. Int. 2023, 39, 1–27. [Google Scholar] [CrossRef]
  7. Arooj, A.; Rabail, R.; Naeem, M.; Goksen, G.; Xu, B.; Aadil, R.M. A Comprehensive Review of the Bioactive Components of Sesame Seeds and Their Impact on Bone Health Issues in Postmenopausal Women. Food Funct. 2023, 14, 4966–4980. [Google Scholar] [CrossRef] [PubMed]
  8. Ramírez-Coronel, A.A.; Ali Alhilali, K.A.; Basheer Ahmed, Y.; Almalki, S.G.; Karimian, J. Effect of Sesame (Sesamum indicum L.) Consumption on Glycemic Control in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Phyther. Res. 2023. Online ahead of print. [Google Scholar] [CrossRef]
  9. Oboulbiga, E.B.; Douamba, Z.; Compaoré-Sérémé, D.; Semporé, J.N.; Dabo, R.; Semde, Z.; Tapsoba, F.W.-B.; Hama-Ba, F.; Songré-Ouattara, L.T.; Parkouda, C.; et al. Physicochemical, Potential Nutritional, Antioxidant and Health Properties of Sesame Seed Oil: A Review. Front. Nutr. 2023, 10, 1127926. [Google Scholar] [CrossRef]
  10. Sankar, D.; Ali, A.; Sambandam, G.; Rao, R. Sesame Oil Exhibits Synergistic Effect with Anti-Diabetic Medication in Patients with Type 2 Diabetes Mellitus. Clin. Nutr. 2011, 30, 351–358. [Google Scholar] [CrossRef]
  11. Baxevanis, G.K.; Sakketou, E.-K.I.; Tentolouris, N.K.; Karathanos, V.T.; Fragkiadakis, G.A.; Kanellos, P.T. Tahini Consumption Improves Metabolic and Antioxidant Status Biomarkers in the Postprandial State in Healthy Males. Eur. Food Res. Technol. 2021, 247, 2721–2728. [Google Scholar] [CrossRef]
  12. Sakketou, E.-K.I.; Baxevanis, G.K.; Tentolouris, N.K.; Konstantonis, G.D.; Karathanos, V.T.; Fragkiadakis, G.A.; Kanellos, P.T. Tahini Consumption Affects Blood Pressure and Endothelial Function in Healthy Males. J. Hum. Hypertens. 2022, 36, 1128–1132. [Google Scholar] [CrossRef] [PubMed]
  13. Rainero, G.; Bianchi, F.; Rizzi, C.; Cervini, M.; Giuberti, G.; Simonato, B. Breadstick Fortification with Red Grape Pomace: Effect on Nutritional, Technological and Sensory Properties. J. Sci. Food Agric. 2022, 102, 2545–2552. [Google Scholar] [CrossRef]
  14. Monteiro, G.C.; Minatel, I.O.; Junior, A.P.; Gomez-Gomez, H.A.; de Camargo, J.P.C.; Diamante, M.S.; Pereira Basílio, L.S.; Tecchio, M.A.; Pereira Lima, G.P. Bioactive Compounds and Antioxidant Capacity of Grape Pomace Flours. LWT 2021, 135, 110053. [Google Scholar] [CrossRef]
  15. Morsy, M.K.; Sami, R.; Algarni, E.; Al-Mushhin, A.A.; Benajiba, N.; Almasoudi, A.G.; Mekawi, E. Phytochemical Profile and Antioxidant Activity of Sesame Seed (Sesamum Indicum) By-Products for Stability and Shelf Life Improvement of Refined Olive Oil. Antioxidants 2022, 11, 338. [Google Scholar] [CrossRef]
  16. Drosou, C.; Kyriakopoulou, K.; Bimpilas, A.; Tsimogiannis, D.; Krokida, M. A Comparative Study on Different Extraction Techniques to Recover Red Grape Pomace Polyphenols from Vinification Byproducts. Ind. Crops Prod. 2015, 75, 141–149. [Google Scholar] [CrossRef]
  17. Bagchi, D.; Bagchi, M.; Stohs, S.J.; Das, D.K.; Ray, S.D.; Kuszynski, C.A.; Joshi, S.S.; Pruess, H.G. Free Radicals and Grape Seed Proanthocyanidin Extract: Importance in Human Health and Disease Prevention. Toxicology 2000, 148, 187–197. [Google Scholar] [CrossRef] [PubMed]
  18. Xia, E.-Q.; Deng, G.-F.; Guo, Y.-J.; Li, H.-B. Biological Activities of Polyphenols from Grapes. Int. J. Mol. Sci. 2010, 11, 622–646. [Google Scholar] [CrossRef]
  19. Zhao, D.; Simon, J.E.; Wu, Q. A Critical Review on Grape Polyphenols for Neuroprotection: Strategies to Enhance Bioefficacy. Crit. Rev. Food Sci. Nutr. 2020, 60, 597–625. [Google Scholar] [CrossRef]
  20. Sridhar, K.; Charles, A.L. Fortification Using Grape Extract Polyphenols—A Review on Functional Food Regulations. Int. J. Food Sci. Technol. 2021, 56, 3742–3751. [Google Scholar] [CrossRef]
  21. Erem, E.; Icyer, N.C.; Tatlisu, N.B.; Kilicli, M.; Kaderoglu, G.H.; Toker, Ö.S. A New Trend among Plant-Based Food Ingredients in Food Processing Technology: Aquafaba. Crit. Rev. Food Sci. Nutr. 2021, 63, 4467–4484. [Google Scholar] [CrossRef] [PubMed]
  22. Alsalman, F.B.; Tulbek, M.; Nickerson, M.; Ramaswamy, H.S. Evaluation of Factors Affecting Aquafaba Rheological and Thermal Properties. LWT 2020, 132, 109831. [Google Scholar] [CrossRef]
  23. Nasopoulou, C.; Karantonis, H.C.; Detopoulou, M.; Demopoulos, C.A.; Zabetakis, I. Exploiting the Anti-Inflammatory Properties of Olive (Olea Europaea) in the Sustainable Production of Functional Food and Neutraceuticals. Phytochem. Rev. 2014, 13, 445–458. [Google Scholar] [CrossRef]
  24. Demopoulos, C.A.; Karantonis, H.C.; Antonopoulou, S. Platelet Activating Factor—A Molecular Link between Atherosclerosis Theories. Eur. J. Lipid Sci. Technol. 2003, 105, 705–716. [Google Scholar] [CrossRef]
  25. Karantonis, H.C.; Tsantila, N.; Stamatakis, G.; Samiotaki, M.; Panayotou, G.; Antonopoulou, S.; Demopoulos, C.A. Bioactive Polar Lipids in Olive Oil, Pomace and Waste Byproducts. J. Food Biochem. 2008, 32, 443–459. [Google Scholar] [CrossRef]
  26. He, Y.; Purdy, S.K.; Tse, T.J.; Tar’an, B.; Meda, V.; Reaney, M.J.T.; Mustafa, R. Standardization of Aquafaba Production and Application in Vegan Mayonnaise Analogs. Foods 2021, 10, 1978. [Google Scholar] [CrossRef] [PubMed]
  27. Włodarczyk, K.; Zienkiewicz, A.; Szydłowska-Czerniak, A. Radical Scavenging Activity and Physicochemical Properties of Aquafaba-Based Mayonnaises and Their Functional Ingredients. Foods 2022, 11, 1129. [Google Scholar] [CrossRef]
  28. Bligh, E.G.; Dyer, W.J. A Rapid Method of Total Lipid Extraction and Purification. Can. J. Biochem. Physiol. 1959, 37, 911–917. [Google Scholar] [CrossRef]
  29. Singleton, V.L.; Rossi, J.A. Colorimetry of Total Phenolics with Phosphomolybdic-Phosphotungstic Acid Reagents. Am. J. Enol. Vitic. 1965, 16, 144–158. [Google Scholar] [CrossRef]
  30. Moore, J.; Yu, L. Methods for Antioxidant Capacity Estimation of Wheat and Wheat-based Food Products. In Wheat Antioxid; John Wiley & Sons, Inc.: Hoboken, NJ, USA, 2007; pp. 118–172. ISBN 9780470228333. [Google Scholar]
  31. Özyürek, M.; Güçlü, K.; Apak, R. The Main and Modified CUPRAC Methods of Antioxidant Measurement. TrAC Trends Anal. Chem. 2011, 30, 652–664. [Google Scholar] [CrossRef]
  32. Benzie, I.F.F.; Strain, J.J. The Ferric Reducing Ability of Plasma (FRAP) as a Measure of “Antioxidant Power”: The FRAP Assay. Anal. Biochem. 1996, 239, 70–76. [Google Scholar] [CrossRef] [PubMed]
  33. Michalaki, A.; Iliopoulou, E.N.; Douvika, A.; Nasopoulou, C.; Skalkos, D.; Karantonis, H.C. Bioactivity of Grape Skin from Small-Berry Muscat and Augustiatis of Samos: A Circular Economy Perspective for Sustainability. Sustainability 2022, 14, 14576. [Google Scholar] [CrossRef]
  34. Shanmuganayagam, D.; Beahm, M.R.; Osman, H.E.; Folts, J.D.; Krueger, C.G.; Reed, J.D. Grape Seed and Grape Skin Extracts Elicit a Greater Antiplatelet Effect When Used in Combination than When Used Individually in Dogs and Humans. J. Nutr. 2002, 132, 3592–3598. [Google Scholar] [CrossRef]
  35. Freedman, J.E.; Keaney, J.F. Vitamin E Inhibition of Platelet Aggregation Is Independent of Antioxidant Activity. J. Nutr. 2001, 131, 374S–377S. [Google Scholar] [CrossRef]
  36. Vorobyova, V.; Vasyliev, G.; Skiba, M.; Frolenkova, S.; Zaporozhets, J.; Gnatko, O.; Linyucheva, O. Green Extraction of Phenolic Compounds from Grape Pomace by Deep Eutectic Solvent Extraction: Physicochemical Properties, Antioxidant Capacity. Chem. Pap. 2023, 77, 2447–2458. [Google Scholar] [CrossRef]
  37. Atanacković Krstonošić, M.; Sazdanić, D.; Ćirin, D.; Maravić, N.; Mikulić, M.; Cvejić, J.; Krstonošić, V. Aqueous Solutions of Non-Ionic Surfactant Mixtures as Mediums for Green Extraction of Polyphenols from Red Grape Pomace. Sustain. Chem. Pharm. 2023, 33, 101069. [Google Scholar] [CrossRef]
  38. Huamán-Castilla, N.L.; Gajardo-Parra, N.; Pérez-Correa, J.R.; Canales, R.I.; Martínez-Cifuentes, M.; Contreras-Contreras, G.; Mariotti-Celis, M.S. Enhanced Polyphenols Recovery from Grape Pomace: A Comparison of Pressurized and Atmospheric Extractions with Deep Eutectic Solvent Aqueous Mixtures. Antioxidants 2023, 12, 1446. [Google Scholar] [CrossRef]
  39. Bochenek, H.; Francis, N.; Santhakumar, A.B.; Blanchard, C.L.; Chinkwo, K.A. The Antioxidant and Anticancer Properties of Chickpea Water and Chickpea Polyphenol Extracts In Vitro. Cereal Chem. 2023, 100, 895–903. [Google Scholar] [CrossRef]
  40. Tripathi, A.; Varma, A.; Mishra, S. Changes in Phytic Acid, Polyphenol, Free Fatty Acid Content and Calorific Value in Chickpea Varieties during Storage. Int. J. Chem. Stud. 2020, 8, 3496–3501. [Google Scholar] [CrossRef]
  41. Rodrigo, R.; Gil-Becerra, D. Implications of Polyphenols on Endogenous Antioxidant Defense Systems in Human Diseases. In Polyphenols in Human Health and Disease; Elsevier: Amsterdam, The Netherlands, 2014; pp. 201–217. [Google Scholar]
  42. de Mello Andrade, J.M.; Fasolo, D. Polyphenol Antioxidants from Natural Sources and Contribution to Health Promotion. In Polyphenols in Human Health and Disease; Elsevier: Amsterdam, The Netherlands, 2014; pp. 253–265. [Google Scholar]
  43. García-Sánchez, A.; Miranda-Díaz, A.G.; Cardona-Muñoz, E.G. The Role of Oxidative Stress in Physiopathology and Pharmacological Treatment with Pro- and Antioxidant Properties in Chronic Diseases. Oxid. Med. Cell. Longev. 2020, 2020, 1–16. [Google Scholar] [CrossRef]
  44. Juszczyk, G.; Mikulska, J.; Kasperek, K.; Pietrzak, D.; Mrozek, W.; Herbet, M. Chronic Stress and Oxidative Stress as Common Factors of the Pathogenesis of Depression and Alzheimer’s Disease: The Role of Antioxidants in Prevention and Treatment. Antioxidants 2021, 10, 1439. [Google Scholar] [CrossRef] [PubMed]
  45. Untea, A.E.; Varzaru, I.; Vlaicu, P.A.; Turcu, R.P.; Panaite, T.D. Studies on Antioxidant Activities of Grape Pomace Using In Vitro, Ex Vivo, and In Vivo Models. J. Food Meas. Charact. 2023, 17, 121–128. [Google Scholar] [CrossRef]
  46. Giusti, F.; Capuano, E.; Sagratini, G.; Pellegrini, N. A Comprehensive Investigation of the Behaviour of Phenolic Compounds in Legumes during Domestic Cooking and In Vitro Digestion. Food Chem. 2019, 285, 458–467. [Google Scholar] [CrossRef]
  47. Siah, S.; Wood, J.A.; Agboola, S.; Konczak, I.; Blanchard, C.L. Effects of Soaking, Boiling and Autoclaving on the Phenolic Contents and Antioxidant Activities of Faba Beans (Vicia faba L.) Differing in Seed Coat Colours. Food Chem. 2014, 142, 461–468. [Google Scholar] [CrossRef] [PubMed]
  48. Fragopoulou, E.; Antonopoulou, S.; Nomikos, T.; Demopoulos, C.A. Structure Elucidation of Phenolic Compounds from Red/White Wine with Antiatherogenic Properties. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 2003, 1632, 90–99. [Google Scholar] [CrossRef] [PubMed]
  49. Fragopoulou, E.; Nomikos, T.; Karantonis, H.C.; Apostolakis, C.; Pliakis, E.; Samiotaki, M.; Panayotou, G.; Antonopoulou, S. Biological Activity of Acetylated Phenolic Compounds. J. Agric. Food Chem. 2007, 55, 80–89. [Google Scholar] [CrossRef] [PubMed]
  50. Singh, B.; Singh, J.P.; Kaur, A.; Singh, N. Phenolic Composition and Antioxidant Potential of Grain Legume Seeds: A Review. Food Res. Int. 2017, 101, 1–16. [Google Scholar] [CrossRef]
  51. Rodríguez, L.; Plaza, A.; Méndez, D.; Carrasco, B.; Tellería, F.; Palomo, I.; Fuentes, E. Antioxidant Capacity and Antiplatelet Activity of Aqueous Extracts of Common Bean (Phaseolus vulgaris L.) Obtained with Microwave and Ultrasound Assisted Extraction. Plants 2022, 11, 1179. [Google Scholar] [CrossRef]
Figure 1. Representation of the fortification materials used: (A) defatted sesame cake; (B) red grape pomace of Limnio variety; (C) lyophilized extract of red grape pomace of Limnio variety with defatted sesame cake; and (D) freeze-dried aquafaba from Panagia variety Lemnian chickpeas.
Figure 1. Representation of the fortification materials used: (A) defatted sesame cake; (B) red grape pomace of Limnio variety; (C) lyophilized extract of red grape pomace of Limnio variety with defatted sesame cake; and (D) freeze-dried aquafaba from Panagia variety Lemnian chickpeas.
Applsci 13 09626 g001
Figure 2. Human plasma oxidation assay results, expressed in µmol Trolox/g final product. Control: tahini; C: mixture of tahini and sesame cake; LC: mixture of tahini, sesame cake and lyophilized pomace extract; AC: mixture of tahini, sesame cake and freeze-dried aquafaba; LAC: mixture of tahini, sesame cake, lyophilized pomace extract and freeze-dried aquafaba; Cake: sesame cake; LMU: lyophilized pomace extract; and AF: freeze-dried aquafaba. Results are expressed as mean ± standard deviation (n = 3). Samples without a common letter (a–d) are significantly different according to Tukey’s test.
Figure 2. Human plasma oxidation assay results, expressed in µmol Trolox/g final product. Control: tahini; C: mixture of tahini and sesame cake; LC: mixture of tahini, sesame cake and lyophilized pomace extract; AC: mixture of tahini, sesame cake and freeze-dried aquafaba; LAC: mixture of tahini, sesame cake, lyophilized pomace extract and freeze-dried aquafaba; Cake: sesame cake; LMU: lyophilized pomace extract; and AF: freeze-dried aquafaba. Results are expressed as mean ± standard deviation (n = 3). Samples without a common letter (a–d) are significantly different according to Tukey’s test.
Applsci 13 09626 g002
Figure 3. PAF inhibition toward PRP assay results expressed as an equivalent amount of mg final product required for 50% inhibition (IC50). Control: tahini; C: mixture of tahini and sesame cake; LC: mixture of tahini, sesame cake and lyophilized pomace extract; AC: mixture of tahini, sesame cake and freeze-dried aquafaba; LAC: mixture of tahini, sesame cake, lyophilized pomace extract and freeze-dried aquafaba; Cake: sesame cake; LMU: lyophilized pomace extract; and AF: freeze-dried aquafaba; n.d. stands for not detected. Results are expressed as mean ± standard deviation (n = 3). Samples without a common letter (a–e) are significantly different according to Tukey’s test.
Figure 3. PAF inhibition toward PRP assay results expressed as an equivalent amount of mg final product required for 50% inhibition (IC50). Control: tahini; C: mixture of tahini and sesame cake; LC: mixture of tahini, sesame cake and lyophilized pomace extract; AC: mixture of tahini, sesame cake and freeze-dried aquafaba; LAC: mixture of tahini, sesame cake, lyophilized pomace extract and freeze-dried aquafaba; Cake: sesame cake; LMU: lyophilized pomace extract; and AF: freeze-dried aquafaba; n.d. stands for not detected. Results are expressed as mean ± standard deviation (n = 3). Samples without a common letter (a–e) are significantly different according to Tukey’s test.
Applsci 13 09626 g003
Table 1. Antioxidant activity of tahini fortified with different amounts of red grape pomace of Limnio variety extract.
Table 1. Antioxidant activity of tahini fortified with different amounts of red grape pomace of Limnio variety extract.
% Fortification μmol Trolox/g
026.5 ± 1.3 a
0.2529.2 ± 1.6 ab
0.530.0 ± 1.2 bc
1.031.8 ± 1.8 cd
2.035.8 ± 1.6 e
4.043.5 ± 2.7 f
Results are presented as mean ± standard deviation of μmol Trolox per gram of fortified sample that corresponded to 50% radical scavenging, based on ABTS assay. Samples without a common letter (a–f) are significantly different according to Tukey’s test.
Table 3. Results of total phenolics and total flavonoids.
Table 3. Results of total phenolics and total flavonoids.
SamplesTotal Phenolics
(mg GAE/g)
Total Flavonoids
(mg RE/g)
Control6.02 ± 0.03 a4.76 ± 0.1 ae
C5.82 ± 0.16 a4.49 ± 0.01 ac
LC9.01 ± 0.12 b9 ± 0.36 b
AC7.34 ± 0.34 c4.07 ± 0.04 c
LAC10.71 ± 0.18 d8.45 ± 0.14 d
Cake6.89 ± 0.19 c5.01 ± 0.02 e
LMU44.86 ± 3.32 e61.76 ± 3.74 f
AF18.87 ± 0.66 f1.1 ± 0.03 g
Results for fortified tahini samples and raw materials are expressed as mean ± standard deviation (n = 3) in mg GAE/g final product for total phenolics and in mg RE/g final product for total flavonoids. Control: tahini; C: mixture of tahini and sesame cake; LC: mixture of tahini, sesame cake and lyophilized pomace extract; AC: mixture of tahini, sesame cake and freeze-dried aquafaba; LAC: mixture of tahini, sesame cake, lyophilized pomace extract and freeze-dried aquafaba; Cake: sesame cake; LMU: lyophilized pomace extract; AF: freeze-dried aquafaba; GAE: gallic acid equivalents; and RE: rutin equivalents. In each column, values without a common letter are significantly different according to Tukey’s test.
Table 4. Results of antioxidant capacity.
Table 4. Results of antioxidant capacity.
SamplesABTS DPPH CUPRACFRAP
Control26.3 ± 0.36 a12.2 ± 0.18 a46.1 ± 2.14 a26.8 ± 0.75 a
C25.3 ± 0.72 a11.6 ± 0.18 a46.1 ± 1.44 a26.9 ± 0.50 a
LC47.8 ± 2.50 b20.9 ± 0.46 b75.0 ± 2.22 b43.7 ± 1.60 b
AC31.6 ± 0.86 c12.0 ± 0.19 a49.6 ± 2.60 a26.9 ± 0.62 a
LAC52.8 ± 0.66 b20.1 ± 1.65 b81.8 ± 0.44 c46.4 ± 3.99 b
Cake31.1 ± 2.71 c12.2 ± 0.32 a51.2 ± 1.03 a29.9 ± 0.08 a
LMU338.3 ± 2.54 d181.7 ± 10.1 c488.0 ± 5.04 d263.3 ± 7.98 c
AF38.8 ± 3.00 e10.6 ± 1.10 a62.7 ± 4.46 e26.4 ± 2.34 a
Results concerning ABTS, DPPH, CUPRAC and FRAP are expressed as mean ± standard deviation (n = 3) μmol trolox/g final product. Control: tahini; C: mixture of tahini and sesame cake; LC: mixture of tahini, sesame cake and lyophilized pomace extract; AC: mixture of tahini, sesame cake and freeze-dried aquafaba; LAC: mixture of tahini, sesame cake, lyophilized pomace extract and freeze-dried aquafaba; Cake: sesame cake; LMU: lyophilized pomace extract; and AF: freeze-dried aquafaba. Values in each column without a common letter are significantly different according to Tukey’s test.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Achilladelis, P.; Petsas, A.S.; Karantonis, H.C. Effect of Fortification of Tahini with Natural Plant Origin Raw Materials on Its Bioactivity. Appl. Sci. 2023, 13, 9626. https://doi.org/10.3390/app13179626

AMA Style

Achilladelis P, Petsas AS, Karantonis HC. Effect of Fortification of Tahini with Natural Plant Origin Raw Materials on Its Bioactivity. Applied Sciences. 2023; 13(17):9626. https://doi.org/10.3390/app13179626

Chicago/Turabian Style

Achilladelis, Panagiotis, Andreas Stergios Petsas, and Haralabos Christos Karantonis. 2023. "Effect of Fortification of Tahini with Natural Plant Origin Raw Materials on Its Bioactivity" Applied Sciences 13, no. 17: 9626. https://doi.org/10.3390/app13179626

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop